Congresswoman Schrier Introduces Bipartisan Legislation to Expand Type 1 Diabetes Screening
ketoacidosis and potentially allow for the use of therapeutics to delay the clinical onset of the condition, helping
Full-text search across every press release in the archive. Matches the title and body, with English stemming, “vote” catches “voted” and “voting.”
102 results for “therapeutics” · House · press release
ketoacidosis and potentially allow for the use of therapeutics to delay the clinical onset of the condition, helping
Vehicle Flammability Standards Study Act and Stem Cell Therapeutic and Research Reauthorization Act . Together, the bills advance … bill is available HERE . The Stem Cell Therapeutic and Research Reauthorization Act For patients facing blood cancers, sickle
Tick Act , and HR 5160 , the Stem Cell Therapeutic and Research Reauthorization Act of 2025 —which will … wait any longer.” HR 5160, the Stem Cell Therapeutic and Research Reauthorization Act of 2025 Smith’s second
lactating individuals in clinical trials for vaccines and therapeutics, a priority supported by BMHC. $7 million in funding
Smith (R-NJ)—HR 5160 , the Stem Cell Therapeutic and Research Reauthorization … conditions,” said Smith. HR 5160, the Stem Cell Therapeutic and Research Reauthorization Act of 2025 “HR 5160 will
people can safely access life-saving vaccines and therapeutics.” “The American College of Obstetricians and Gynecologists (ACOG … critical data on the effects of medications and therapeutics taken during pregnancy and lactation,” said ACOG President Camille
advance its evaluation of rapid-acting novel therapeutics – including entactogen- and psychedelic-assisted therapies – for the treatment … ongoing evaluation of rapid-acting novel therapeutics, including entactogen- and psychedelic-assisted therapies, for mental health conditions affecting
advance its evaluation of rapid-acting novel therapeutics—including entactogen- and psychedelic-assisted therapies—for the treatment
Smith is the author of the Stem Cell Therapeutic and Research Act of 2005 ( PL 109-129 ), groundbreaking … newest reauthorization of the law, the Stem Cell Therapeutic and Research Reauthorization Act of 2025 ( HR 5160 ), which
Dietary Guidelines for Americans, 2025-2030—supports therapeutic carbohydrate reduction, including low-carbohydrate and ketogenic interventions, as effective
Dietary Guidelines for Americans, 2025-2030—supports therapeutic carbohydrate reduction, including low-carbohydrate and ketogenic interventions, as effective
Executive Order advancing federal research into the therapeutic potential of ibogaine: “Today marks a decisive step forward
blood-brain-barrier and reach the tumor at therapeutic levels is a major obstacle for most chemotherapies
including religious diets and more than a dozen therapeutic diets, as well as cultural preferences. Menus are reviewed
including religious diets and more than a dozen therapeutic diets, as well as cultural preferences. Menus are reviewed
including religious diets and more than a dozen therapeutic diets, as well as cultural preferences. Menus are reviewed
Butler, President and Chief Executive Officer of Akebia Therapeutics. Click here to watch Congressman Buchanan’s remarks. Here
Butler, President and Chief Executive Officer of Akebia Therapeutics, on how the legislation would help sustain innovation
this neurodegenerative disorder, and encourage research to develop therapeutics and a cure.” The causes of Multiple System Atrophy
will be used to research the biological and therapeutic effects of varying doses of radiation on the body
introduced the Harmonizing Environmental Analyses and Launching Therapeutic Hubs to Yield Bolstered Research and Innovation in Neurological Science
Focused ultrasound is an emerging non-invasive therapeutic technology that employs high-frequency soundwaves to precisely target areas
accelerating innovation for Patients with few or no therapeutic options. Because life sciences R&D is complex
environment across our campus. From updated medical and therapeutic equipment to ADA-accessible improvements and disaster preparedness, these
accelerating innovation for Patients with few or no therapeutic options. Because life sciences R&D is complex, costly